000 01614 a2200445 4500
005 20250515082510.0
264 0 _c20071127
008 200711s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/j.bmcl.2007.08.017
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKeith, John M
245 0 0 _aDual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cOct 2007
300 _a5325-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a5-Hydroxytryptophan
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBrain
_xmetabolism
650 0 4 _aDrug Design
650 0 4 _aHistamine Antagonists
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aIndicators and Reagents
650 0 4 _aRats
650 0 4 _aReceptors, Histamine H3
_xdrug effects
650 0 4 _aSerotonin Antagonists
_xchemical synthesis
650 0 4 _aSerotonin Plasma Membrane Transport Proteins
_xdrug effects
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTetrahydroisoquinolines
_xchemical synthesis
700 1 _aBarbier, Ann J
700 1 _aWilson, Sandy J
700 1 _aMiller, Kirstin
700 1 _aBoggs, Jamin D
700 1 _aFraser, Ian C
700 1 _aMazur, Curt
700 1 _aLovenberg, Timothy W
700 1 _aCarruthers, Nicholas I
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 17
_gno. 19
_gp. 5325-9
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2007.08.017
_zAvailable from publisher's website
999 _c17294813
_d17294813